1. We suggest these non-approved LAA closure devices not be used, except in research protocols or in systematically-documented use protocols in patients at high risk of stroke (CHADS₂≥2) for whom antithrombotic therapy is precluded. (Conditional Recommendation, Low Quality Evidence)